First-in-human phase 1 trial of the safety, tolerability, pharmacokinetics of BY101298: Initial report from dose escalation cohort

被引：0
|
作者：
Yu, Jinming
Sun, Yuping
Dang, Qi
Zhang, Yan
Du, Jintong
Wei, Yonggang
Ye, Fei
Liu, Rui
Zhao, Qi
Li, Zhiyong
机构：
[1] Shandong Univ, Shandong Canc Hosp, Jinan, Peoples R China
[2] Shandong Canc Hosp, Jinan, Peoples R China
[3] Shandong Canc Hosp, Jinan, Shandong, Peoples R China
[4] Shandong First Med Univ, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[5] Shandong Acad Med Sci, Jinan, Shandong, Peoples R China
[6] Chengdu Baiyu Pharmaceut Co Ltd, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15132
引用
收藏
页数：1
相关论文
共 50 条
  • [1] First-in-human phase 1 trial of the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of WSD0922-Fu: Initial report from dose escalation cohort.
    Kizilbash, Sani Haider
    Jaeckle, Kurt A.
    Mrugala, Maciej M.
    Allred, Jacob B.
    Safgren, Stephanie L.
    Lammers, Anita Aracelli
    Zhong, Wei
    Leventakos, Konstantinos
    Mansfield, Aaron Scott
    Shanshal, Mohamed
    Ma, Wen Wee
    Uhm, Joon H.
    Campian, Jian Li
    Ruff, Michael W.
    Sener, Ugur
    Galanis, Evanthia
    Burns, Terry C.
    Giannini, Caterina
    Sarkaria, Jann Nagina
    Adjei, Alex A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors
    Bendell, Johanna C.
    Patel, Manish R.
    Moore, Kathleen N.
    Chua, Cynthia C.
    Arkenau, Hendrik-Tobias
    Dukart, Gary
    Harrow, Kim
    Liang, Chris
    ONCOLOGIST, 2019, 24 (04): : 455 - E121
  • [3] First-in-human, randomized dose-escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF-06480605 in healthy subjects
    Banfield, Christopher
    Rudin, Dan
    Bhattacharya, Indranil
    Goteti, Kosalaram
    Li, Gang
    Hassan-Zahraee, Mina
    Brown, Lisa S.
    Hung, Kenneth E.
    Pawlak, Sylvester
    Lepsy, Christopher
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (04) : 812 - 824
  • [4] Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study
    An, Guohua
    Murry, Daryl J.
    Gajurel, Kiran
    Bach, Thanh
    Deye, Greg
    Stebounova, Larissa, V
    Codd, Ellen E.
    Horton, John
    Gonzalez, Armando E.
    Garcia, Hector H.
    Ince, Dilek
    Hodgson-Zingman, Denice
    Nomicos, Effie Y. H.
    Conrad, Thomas
    Kennedy, Jessie
    Jones, Walt
    Gilma, Robert H.
    Winokur, Patricia
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [5] First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat
    Antonijoan, Rosa Maria
    Ferrero-Cafiero, Juan Manuel
    Coimbra, Jimena
    Puntes, Montse
    Martinez-Colomer, Joan
    Arevalo, Maria Isabel
    Mascaro, Cristina
    Molinero, Cesar
    Buesa, Carlos
    Maes, Tamara
    CNS DRUGS, 2021, 35 (03) : 331 - 344
  • [6] First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat
    Rosa María Antonijoan
    Juan Manuel Ferrero-Cafiero
    Jimena Coimbra
    Montse Puntes
    Joan Martínez-Colomer
    María Isabel Arévalo
    Cristina Mascaró
    Cesar Molinero
    Carlos Buesa
    Tamara Maes
    CNS Drugs, 2021, 35 : 331 - 344
  • [7] SAFETY AND IMMUNOGENICITY OF A REPLICATION DEFICIENT SIMIAN ADENOVIRAL VECTORED CHIKUNGUNYA VACCINE: A PHASE I, FIRST-IN-HUMAN, DOSE ESCALATION TRIAL
    Folegatti, Pedro M.
    Harrison, Kate
    Lopez, Fernando Ramos
    Tilley, Mark W.
    Lopez-Camacho, Cesar
    Kim, Young C.
    Preciado-Llanes, Lorena
    Rossi, Shannan L.
    Poulton, Ian
    Jenkin, Daniel
    Datoo, Mehreen
    Themistocleous, Yrene
    Lawrie, Alison
    Roberts, Rachel
    Ewer, Katie
    Berrie, Eleanor
    Hill, Adrian
    Reyes-Sandoval, Arturo
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 19 - 19
  • [8] A First-in-Human Safety, Tolerability, and Pharmacokinetics Study of Benapenem in Healthy Chinese Volunteers
    Zhao, Cai-Yun
    Lv, Yuan
    Zhu, Yan
    Wei, Min-Ji
    Liu, Meng-Ying
    Ji, Xi-Wei
    Kang, Zi-Sheng
    Xia, Ya-Hong
    Tian, Ji-Hong
    Ma, Yan
    Liu, Yan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)
  • [9] Safety, Tolerability, and Pharmacokinetics of a Novel Oral Phosphodiesterase 4 Inhibitor, ME3183: First-in-Human Phase 1 Study
    Kato, Seiji
    Cho, Naoki
    Koresawa, Tomokazu
    Otake, Kazunari
    Kano, Akiko
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (04): : 341 - 348
  • [10] A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers
    Laties, Alan
    Rich, Cadmus C.
    Stoltz, Randall
    Humbert, Vernon
    Brickman, Chaim
    McVicar, William
    Baumgartner, Rudolf A.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (08) : 548 - 554
12345